obstructive hypertrophic cardiomyopathy
Showing 1 - 25 of 7,165
Mavacamten in Korean Symptomatic Obstructive Hypertrophic
Not yet recruiting
- Obstructive Hypertrophic Cardiomyopathy
-
Seoul, Korea, Republic ofBristol-Myers Squibb YH
Nov 23, 2023
Liwen Procedure in Obstructive Hypertrophic Cardiomyopathy on
Active, not recruiting
- Hypertrophic Cardiomyopathy
- Arrhythmia
- Percutaneous Intramyocardial Septal Radiofrequency Ablation for hypertrophic obstructive cardiomyopathy (Liwen Procedure)
-
Xi'an, Shaanxi, ChinaUltrasound Medicine Department of Xijing Hospital, Fourth Milita
Sep 4, 2023
Obstructive Hypertrophic Cardiomyopathy Trial (HRS-1893, Placebo)
Not yet recruiting
- Obstructive Hypertrophic Cardiomyopathy
- HRS-1893
- Placebo
- (no location specified)
May 18, 2023
Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy Trial in Anchorage, Portland (Aficamten, Placebo)
Recruiting
- Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy
- Aficamten
- Placebo
-
Anchorage, Alaska
- +1 more
Oct 12, 2023
Obstructive Hypertrophic Cardiomyopathy Trial in Milan (pace maker implant guided by acute hemodynamic testing)
Recruiting
- Obstructive Hypertrophic Cardiomyopathy
- pace maker implant guided by acute hemodynamic testing
-
Milan, ItalyIstituto Auxologico Italiano
Mar 6, 2023
Obstructive Hypertrophic Cardiomyopathy
Completed
- Microvascular Dysfunction
- +2 more
-
Beijing, Beijing, ChinaFuwai Hospital, China National Center for Cardiovascular Disease
Jan 11, 2023
Cryoenergy to Faciltate Myectomy in Hypertrophic Obstructive
Completed
- Septal Hypertrophy
- Obstructive Hypertrophic Cardiomyopathy
- Cryo myectomy
- Myectomy
-
Milan, ItalyIRCCS Ospedale San Raffaele
Feb 3, 2023
Cardiomyopathy, Hypertrophic Trial in Worldwide (Mavacamten, Placebo)
Not yet recruiting
- Cardiomyopathy, Hypertrophic
- Mavacamten
- Placebo
-
West Hollywood, California
- +9 more
Oct 27, 2023
Hypertrophic Cardiomyopathy Trial in San Francisco (Moderate Intensity Exercise Program)
Recruiting
- Hypertrophic Cardiomyopathy
- Moderate Intensity Exercise Program
-
San Francisco, CaliforniaUniversity of California - San Francisco
Apr 5, 2023
Obstructive Hypertrophic Cardiomyopathy (oHCM) Trial (Aficamten (CK-3773274) (5 mg, 10 mg, 15 mg and 20 mg), Placebo to match
Not yet recruiting
- Obstructive Hypertrophic Cardiomyopathy (oHCM)
- Aficamten (CK-3773274) (5 mg, 10 mg, 15 mg and 20 mg)
- +3 more
- (no location specified)
Mar 2, 2023
Obstructive Hypertrophic Cardiomyopathy Trial in Boston, Kansas City, Omaha
Not yet recruiting
- Obstructive Hypertrophic Cardiomyopathy
- (no location specified)
Aug 3, 2022
Effect of Mavacamten Treatment on Coronary Flow Reserve in oHCM
Not yet recruiting
- Obstructive Hypertrophic Cardiomyopathy
-
Charlottesville, VirginiaUniversity of Virginia
Aug 28, 2023
Patients' Long-Term Survival of Obstructive Hypertrophic
Completed
- Cardiomyopathy
- Obstructive Hypertrophic Cardiomyopathy
-
Bethesda, MarylandNational Heart, Lung and Blood Institute (NHLBI)
May 27, 2022
Non-obstructive Hypertrophic Cardiomyopathy Trial in Denmark (Verapamil, Bisoprolol, Placebo)
Recruiting
- Non-obstructive Hypertrophic Cardiomyopathy
- Verapamil
- +2 more
-
Aarhus N, Denmark
- +6 more
Dec 5, 2022
Obstructive Hypertrophic Cardiomyopathy Trial in China (Aficamten)
Not yet recruiting
- Obstructive Hypertrophic Cardiomyopathy
-
Beijing, China
- +9 more
Oct 31, 2023
Hypertrophic Cardiomyopathy Trial in United States (mavacamten)
Active, not recruiting
- Hypertrophic Cardiomyopathy
-
Scottsdale, Arizona
- +3 more
Jun 10, 2022
Non-obstructive Hypertrophic Cardiomyopathy Trial in United Kingdom, United States (IMB-1018972, Placebo)
Recruiting
- Non-obstructive Hypertrophic Cardiomyopathy
- IMB-1018972
- Placebo
-
La Jolla, California
- +13 more
Oct 11, 2022
Cardiomyopathy, Hypertrophic Obstructive Trial in Chuo-Ku (Mavacamten)
Recruiting
- Cardiomyopathy, Hypertrophic Obstructive
-
Uwajima, Ehime, Japan
- +18 more
Jan 20, 2023
Hypertrophic Obstructive Cardiomyopathy Trial in Wuhan (Transapical beating-heart septal myectomy)
Recruiting
- Hypertrophic Obstructive Cardiomyopathy
- Transapical beating-heart septal myectomy
-
Wuhan, Hubei, ChinaTongji Hospital, Tongji Medical College, Huazhong University of
Jul 14, 2023
Functional Capacity and Quality of Life Following Septal
Recruiting
- Hypertrophic Cardiomyopathy
-
Cleveland, OhioCleveland Clinic
May 3, 2022
Influencing Factors of Liwen Procedure in The Treatment of
Active, not recruiting
- Hypertrophic Obstructive Cardiomyopathy
- Percutaneous Intramyocardial Septal Radiofrequency Ablation for hypertrophic obstructive cardiomyopathy (Liwen Procedure)
-
Xi'an, Shaanxi, ChinaUltrasound Medicine Department of Xijing Hospital, Fourth Milita
Aug 20, 2023
Mitral Regurgitation in Hypertrophic Obstructive Cardiomyopathy:
Completed
- Hypertrophic Obstructive Cardiomyopathy
- Mitral Regurgitation
- Septal myectomy and mitral valve repair with edge-to-edge technique
-
Milan, ItalyIRCCS Ospedale San Raffaele
Apr 28, 2023
Hypertrophic Obstructive Cardiomyopathy Trial
Completed
- Hypertrophic Obstructive Cardiomyopathy
- (no location specified)
Jan 13, 2023
Hypertrophic Obstructive Cardiomyopathy Trial in Wuhan (Minimally invasive transapical septal myectomy for Hypertrophic
Recruiting
- Hypertrophic Obstructive Cardiomyopathy
- Transapical beating-heart septal myectomy
-
Wuhan, Hubei, ChinaTongji Hospital, Tongji Medical College, Huazhong University of
Dec 4, 2022